We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Shire Sues Barr for Infringing Patent on Renal Disease Drug
Shire Sues Barr for Infringing Patent on Renal Disease Drug
March 17, 2009
Shire has sued Barr Laboratories, the wholly owned subsidiary of Teva Pharmaceutical Industries, for infringing its patent on the drug Fosrenol, which reduces serum phosphate in patients with end-stage renal disease.